Jungaberle, Henrik

Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review

Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 122

Psychedelic microdosing: a subreddit analysis

Lea, T., Amada, N., & Jungaberle, H. (2020) · Journal of Psychoactive Drugs

Psychedelics and Drug StudiesNeuroethics, Human Enhancement, Biomedical Innovations

Cited by 115

Positive psychology in the investigation of psychedelics and entactogens: a critical review

Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. (2018) · Neuropharmacology

Psychedelics and Drug StudiesPsychological Well-being and Life Satisfaction

Cited by 70

Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design

Mertens, L. J., Koslowski, M., Betzler, F., Evens, R., Gilles, M., Jungaberle, A., Jungaberle, H., Majić, T., Ströhle, A., Wolff, M., et al. (2022) · Neuroscience Applied

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 41